ArticleMarine drugs2019
Cloning, Expression, and Characterization of a New PL25 Family Ulvan Lyase from Marine Bacterium
Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 46 citations in OpenAlex.
- Characterisation of a phylogenetically distinct PL25 family ulvan lyase from a seaweed biomass enriched metagenome.The FEBS journal · 2026Article
- Structural and functional insights into Uly1040, an ulvan lyase from polysaccharide lyase family 40.Applied and environmental microbiology · 2026Article
- Pseudoalteromonas agarivorans-derived novel ulvan lyase of polysaccharide lyase family 40: Potential application of ulvan and partially hydrolyzed products in cosmetic industry.Journal of industrial microbiology & biotechnology · 2024Article
- Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase fromMarine drugs · 2024Article
- Polysaccharides and oligosaccharides originated from green algae: structure, extraction, purification, activity and applications.Bioresources and bioprocessing · 2024Review
- Sustainable Production ofFoods (Basel, Switzerland) · 2024Review
- Biochemical characterisation of a PL24 ulvan lyase from seaweed-associatedJournal of applied phycology · 2024Article
- Ulvan and Ulva oligosaccharides: a systematic review of structure, preparation, biological activities and applications.Bioresources and bioprocessing · 2023Review
- Recalcitrant cell wall ofAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2022Article
- Isolation, Diversity and Characterization of Ulvan-Degrading Bacteria Isolated from Marine Environments.Molecules (Basel, Switzerland) · 2022Article
- Marine microbial enzymes for the production of algal oligosaccharides and its bioactive potential for application as nutritional supplements.Folia microbiologica · 2022Review
- Biochemical Properties of a New Polysaccharide Lyase Family 25 Ulvan Lyase TsUly25B from Marine BacteriumMarine drugs · 2022Article
- Biomaterials from the sea: Future building blocks for biomedical applications.Bioactive materials · 2021Review
- Marine Polysaccharides: Occurrence, Enzymatic Degradation and Utilization.Chembiochem : a European journal of chemical biology · 2021Review
- Mechanistic Insights into Substrate Recognition and Catalysis of a New Ulvan Lyase of Polysaccharide Lyase Family 24.Applied and environmental microbiology · 2021Article
- Overview on Microbial Enzymatic Production of Algal Oligosaccharides for Nutraceutical Applications.Marine biotechnology (New York, N.Y.) · 2021Review
- Characterization and Function of a Novel Welan Gum Lyase From MarineFrontiers in microbiology · 2021Article
- Genome Mining and Synthetic Biology in Marine Natural Product Discovery.Marine drugs · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Ulvan lyases can degrade ulvan to oligosaccharides with potent biological activity. A new ulvan lyase gene,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.